
HighCape Partners
North America, Maryland, United States, Baltimore
Description
A growth equity firm that invests in companies that are commercializing high-margin life sciences products.
Investor Profile
HighCape Partners has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 40% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (33%)
- Series C (20%)
- Seed (13%)
- Pre Seed (7%)
- Post Ipo Equity (7%)
- Series F (7%)
- Series E (7%)
- Series Unknown (7%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Medical Device
- Pharmaceutical
- Developer Platform
- Fitness
- Personal Health
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.